Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.9 USD | +0.53% | -4.04% | +2.70% |
Apr. 12 | Transcript : Cognition Therapeutics, Inc. - Special Call | |
Mar. 26 | Transcript : Cognition Therapeutics, Inc., Q4 2023 Earnings Call, Mar 26, 2024 |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 73.71M |
---|---|---|---|---|---|
Net income 2024 * | -39M | Net income 2025 * | -64M | EV / Sales 2024 * | - |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-1.94
x | P/E ratio 2025 * |
-1.35
x | Employees | 27 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 89.78% |
Latest transcript on Cognition Therapeutics, Inc.
1 day | +0.53% | ||
1 week | -4.04% | ||
Current month | +4.40% | ||
1 month | +2.15% | ||
3 months | -20.50% | ||
6 months | +50.79% | ||
Current year | +2.70% |
Managers | Title | Age | Since |
---|---|---|---|
Lisa Ricciardi
CEO | Chief Executive Officer | 64 | 19-02-28 |
John Doyle
DFI | Director of Finance/CFO | 46 | 23-04-30 |
Paul J. Tiseo
CTO | Chief Tech/Sci/R&D Officer | - | 22-10-10 |
Members of the board | Title | Age | Since |
---|---|---|---|
Lisa Ricciardi
CEO | Chief Executive Officer | 64 | 19-02-28 |
Brett Monia
BRD | Director/Board Member | 62 | 20-09-30 |
Ellen Richstone
BRD | Director/Board Member | 72 | 21-10-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-17 | 1.9 | +0.53% | 75,904 |
24-04-16 | 1.89 | -1.05% | 121,960 |
24-04-15 | 1.91 | -2.55% | 62,065 |
24-04-12 | 1.96 | -6.22% | 253,578 |
24-04-11 | 2.09 | +5.56% | 274,178 |
Delayed Quote Nasdaq, April 17, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+2.70% | 73.71M | |
-3.39% | 102B | |
+2.61% | 96.09B | |
-1.02% | 22.05B | |
-18.14% | 20.81B | |
-6.87% | 19.06B | |
-40.70% | 16.05B | |
-26.89% | 14.01B | |
+1.12% | 13.38B | |
+22.25% | 11.01B |
- Stock Market
- Equities
- CGTX Stock